RN1701 Injection

· Affiliated Hospital of Nantong University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RN1701 Injection, covering 2026-01-06 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas [Phase 1, Phase 2]